Cutler Group’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
– Sell
-639
Closed -$18K – 4758
2018
Q3
$18K Buy
+639
New +$151K ﹤0.01% 2319
2018
Q2
– Sell
-24
Closed -$1K – 5078
2018
Q1
$1K Buy
24
+10
+71% +$2.62K ﹤0.01% 4228
2017
Q4
$1K Sell
14
-72
-84% -$23.7K ﹤0.01% 4652
2017
Q3
$3K Sell
86
-163
-65% -$57.8K ﹤0.01% 4903
2017
Q2
$7K Buy
249
+206
+479% +$61.7K ﹤0.01% 4584
2017
Q1
$1K Sell
43
-71
-62% – ﹤0.01% 6064
2016
Q4
$1K Sell
114
-72
-39% -$14.4K ﹤0.01% 6218
2016
Q3
$4K Buy
186
+110
+145% +$22.9K ﹤0.01% 5223
2016
Q2
$1K Buy
+76
New +$1K ﹤0.01% 6344

Other funds holding DMK

Cutler Group's DMK Position: Q1 2019 in Review

Cutler Group sold out of DMK Pharmaceuticals (DMK) in Q1 2019, closing a stake of 92 shares — an estimated $14K sold.

Cutler Group first reported a position in DMK in Q1 2016 and held it in 12 quarters. The position peaked at $24K in Q3 2018. 57 funds tracked by Wall St. Rank hold DMK as of Q1 2019.

  • Cutler Group reported no remaining DMK Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Cutler Group sold 92 DMK Pharmaceuticals shares in Q1 2019, an estimated $14K.
  • Cutler Group first reported a position in DMK Pharmaceuticals in Q1 2016 and held it in 12 quarters.
  • Cutler Group's DMK Pharmaceuticals position peaked at $24K in Q3 2018.
  • 57 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q1 2019.

Based on Cutler Group's 13F filing for Q1 2019, filed 10 May 2019.